![]() |
市场调查报告书
商品编码
1848406
农业生技药品市场预测至2032年:按产品类型、来源、作物类型、应用方法和地区分類的全球分析Agricultural Biologicals Market Forecasts to 2032 - Global Analysis By Product Type, Source, Crop Type, Mode of Application, and By Geography |
||||||
根据 Stratistics MRC 的数据,预计 2025 年全球农业生技药品市场规模将达到 175 亿美元,到 2032 年将达到 470 亿美元,预测期内复合年增长率为 15.1%。
农业生技药品市场涵盖生物基作物投入品,例如生物农药、生物肥料、微生物接种剂和生物刺激剂,这些产品能够改善植物健康和产量,同时减少对环境的影响。推动市场成长的因素包括:部分化学农药受到监管限制、农民对永续替代方案的需求,以及为提高产品功效和配方稳定性而进行的研发工作。生技公司与农业相关企业之间的伙伴关係正在加速产品的商业化进程,而数位化应用工具和精准仪器则优化了施用方式。日益增长的认可度和已证实的作物增产效益正在推动这些产品在连续农业和特种农业中的广泛应用。
永续农业实践
全球向永续农业的转型是推动农业生技药品市场发展的重要催化剂。消费者对有机食品的需求不断增长,以及监管机构日益加大力度减少合成化学残留,迫使农民采用生物解决方案。这些产品源自天然成分,与综合虫害管理(IPM)和有机农业通讯协定完美契合。此外,它们还能改善土壤健康和生物多样性,为实现永续农业提供长期策略。从纯粹依赖化学模式转移转向更平衡的生态学方法,是推动市场扩张的根本动力。
监管挑战
农业生技药品市场快速成长的主要障碍之一是复杂且分散的全球监管环境。新生物製药的核准流程漫长、成本高昂,且各国之间标准不一,为生产商带来不确定性。此外,许多生物製药的新型作用机制并不总是能完全契合为传统化学品设计的现有监管架构。这种监管上的模糊性导致产品上市延迟,企业合规成本增加,并阻碍市场发展和推广。
技术进步
先进的发酵技术和精密的配方技术正在提升生物製药的保存期限、稳定性和田间疗效。此外,数据分析和精密农业工具的整合使得生物製药的标靶施用成为可能,从而最大限度地发挥其功效。微生物发现和菌株改良方面的创新也正在催生更强大、更可靠的解决方案。这些技术进步对于克服以往的性能限制、增强种植者的信任至关重要。
不利天气条件影响生物活性
极端天气事件,例如长期干旱、异常暴雨和强烈热浪,会对微生物菌株和生化产品的活性和存活率产生不利影响。这些变化会导致田间试验结果不稳定,并削弱农民的信心。随着气候变迁导致天气更加不稳定,确保产品抗逆性并管理种植者对施用时间和环境适用性的预期,将是该行业面临的关键挑战。
疫情初期,供应链瓶颈、劳动力短缺和物流障碍导致农业生技药品市场受到衝击,产品交付和田间试验被迫延迟。然而,这场危机也凸显了建构具有韧性和永续的粮食系统的重要性。这种认知加速了向生物基农业投入品的长期转型,相关人员纷纷寻求降低对更广泛供应链依赖的风险。因此,在经历了最初的放缓之后,市场重新焕发活力,投资也随之增加,巩固了生物农药在现代农业中的战略重要性。
预计在预测期内,生物农药细分市场将是最大的细分市场。
严格的监管政策逐步淘汰主要合成农药,以及消费者对食品中化学残留物日益增长的抵制,预计将推动生物农药在预测期内占据最大的市场份额。生物农药具有标靶作用机制,可减少对益虫的伤害并最大限度地降低对环境的影响。它们与传统的农药残留管理耕作系统高度相容,因此对许多种植者来说,生物农药是极具吸引力的首选方案。监管支持和强劲的市场需求相结合,已使生物农药稳居农业生技药品的主导地位。
预计在预测期内,微生物学领域将实现最高的复合年增长率。
由于持续不断的研发活动不断释放微生物的巨大潜力,微生物学领域预计在预测期内将保持最高的成长率。微生物产品,包括细菌、真菌和病毒,用途广泛,可用作生物农药、生物刺激剂和生物肥料。它们能够定殖于植物根系并透过多种机制促进植物生长,其作用极为强大。随着製剂技术的进步,产品的保质期和功效不断提升,农民对微生物产品的接受度也随之加快,这使得微生物学成为最具活力和发展最快的领域之一。
预计在预测期内,欧洲地区将占据最大的市场份额。这一领先地位主要归功于欧盟雄心勃勃的「从农场到餐桌」战略,该战略明确规定化学农药的使用量必须减少50%。完善的法律规范和政府对永续实践的大力补贴,为生物製药的推广创造了非常有利的环境。此外,消费者群体日益成熟,对有机和永续生产的食品有着强烈的偏好,这推动了零售层面的需求,使欧洲成为农业生技药品最成熟、领先的市场。
预计亚太地区在预测期内将实现最高的复合年增长率。这一快速增长的驱动力源于迫切需要提高庞大人口的粮食安全,同时也要应对因过度使用化学物质而导致的土壤劣化和环境污染等严峻问题。中国和印度等国的政府正在积极推广生物製药,将其视为一种永续的解决方案。此外,亚太地区拥有广大的农业用地,农民对提高产量意识的不断增强,也为市场扩张和渗透创造了非常有利的条件。
According to Stratistics MRC, the Global Agricultural Biologicals Market is accounted for $17.5 billion in 2025 and is expected to reach $47.0 billion by 2032 growing at a CAGR of 15.1% during the forecast period. Agricultural Biologicals market covers bio-based crop inputs such as biopesticides, biofertilizers, microbial inoculants, and biostimulants that enhance plant health and yield with lower environmental impact. Growth is driven by regulatory restrictions on some chemical pesticides, farmer interest in sustainable alternatives, and R&D that improves efficacy and formulation stability. Partnerships between biotech firms and agri-companies speed commercialization, while digital application tools and precision equipment optimize dosing. Increasing acceptance and demonstrable ROI on crop performance underpin broader adoption across row crops and specialty agriculture
Sustainable Agriculture Practices
The global shift towards sustainable agriculture is a primary catalyst for the agricultural biologicals market. Mounting consumer demand for organic food and growing regulatory pressure to reduce synthetic chemical residues are compelling growers to adopt biological solutions. These products, derived from natural materials, align perfectly with integrated pest management (IPM) and organic farming protocols. Furthermore, they help improve soil health and biodiversity, offering a long-term strategy for resilient farming. This paradigm shift from purely chemical inputs to a more balanced, ecological approach fundamentally drives market expansion.
Regulatory Challenges
A significant barrier to the rapid growth of the agricultural biologicals market is the complex and often fragmented global regulatory landscape. The approval process for new biological products can be lengthy, costly, and inconsistent across different countries, creating uncertainty for manufacturers. Additionally, the novel mode of action of many biologicals does not always fit neatly into existing frameworks designed for conventional chemicals. This regulatory ambiguity can delay product launches and increase compliance costs for companies, thereby restraining the pace of market development and adoption.
Technological Advancements
Advanced fermentation technologies and sophisticated formulation techniques are enhancing the shelf-life, stability, and field efficacy of biological products. Moreover, the integration of data analytics and precision agriculture tools allows for the targeted application of biologicals, maximizing their effectiveness. Innovations in microbial discovery and strain improvement are also leading to more potent and reliable solutions. These technological strides are crucial for overcoming previous performance limitations and building greater trust among growers.
Adverse weather conditions affecting biological efficacy
Extreme weather events, including prolonged droughts, unseasonal heavy rainfall, or severe heatwaves, can adversely impact the viability and activity of microbial strains and biochemicals. This variability can lead to inconsistent results in the field, potentially eroding farmer confidence. As climate change increases weather volatility, ensuring product resilience and managing grower expectations regarding application windows and environmental suitability becomes a critical challenge for the industry.
The pandemic initially disrupted the agricultural biologicals market through supply chain bottlenecks, labor shortages, and logistical hurdles, which delayed product deliveries and field trials. However, the crisis also underscored the critical importance of resilient and sustainable food systems. This awareness accelerated the long-term shift towards bio-based agricultural inputs as stakeholders sought to de-risk from broader supply chain dependencies. Consequently, after an initial slowdown, the market experienced a resurgence in interest and investment, solidifying the strategic importance of biologicals in modern agriculture.
The biopesticides segment is expected to be the largest during the forecast period
The biopesticides segment is expected to account for the largest market share during the forecast period driven by stringent regulatory policies phasing out key synthetic pesticides and rising consumer resistance to chemical residues in food. Biopesticides offer a targeted mode of action, reducing harm to beneficial insects and minimizing environmental impact. Their compatibility with conventional farming systems for residue management makes them an attractive first step into biologicals for many growers. This combination of regulatory push and growing market pull firmly positions biopesticides as the dominant segment in the agricultural biologicals landscape.
The microbials segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the microbials segment is predicted to witness the highest growth rate fueled by relentless research and development that continues to unlock the vast potential of microorganisms. Microbial products, including bacteria, fungi, and viruses, are highly versatile, functioning as biopesticides, biostimulants, and biofertilizers. Their ability to colonize plant roots and promote growth through multiple mechanisms makes them exceptionally powerful. As formulation technologies improve to enhance their shelf-life and efficacy, farmer adoption is accelerating, positioning microbials as the most dynamic and rapidly expanding segment.
During the forecast period, the Europe region is expected to hold the largest market share. This leadership is largely attributed to the European Union's ambitious Farm to Fork strategy, which explicitly mandates a 50% reduction in chemical pesticide use. Supportive regulatory frameworks and substantial government subsidies for sustainable practices create a highly conducive environment for biologicals. Additionally, a sophisticated consumer base with strong preferences for organic and sustainably produced food drives demand from the retail level, making Europe the most mature and dominant market for agricultural biological products.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. This rapid growth is propelled by the pressing need to enhance food security for its large population while addressing severe issues of soil degradation and environmental pollution from chemical overuse. Governments in countries like China and India are actively promoting biologicals as a sustainable solution. Moreover, the presence of a vast agricultural landholding and growing awareness among farmers about yield optimization are creating an exceptionally fertile ground for market expansion and penetration.
Key players in the market
Some of the key players in Agricultural Biologicals Market include BASF SE, Bayer AG, Corteva, Inc., Syngenta Group, UPL Limited, FMC Corporation, Novozymes A/S, Valent BioSciences LLC, Marrone Bio Innovations, Inc., Koppert Biological Systems B.V., Lallemand Inc., Certis Biologicals, Gowan Company, L.L.C., Rovensa Next, De Sangosse, Andermatt Biocontrol AG, SEIPASA S.A., Bioworks, Inc., Vegalab SA, and International Panaacea Limited.
In July 2025, Bayer signed a development and distribution agreement with French pheromones expert company M2i Group for the exclusive distribution of pheromone gels for the Asia-Pacific as well as the Latin America region and the United States building on its successful collaboration and related product launches in Europe and Africa.
In October 2024, BASF expands its BioSolutions offering by incorporating seaweed biostimulants from Acadian Plant Health(TM), a renowned marine plant harvesting, cultivation, and Extraction Company based in Dartmouth, Canada. "Now more than ever, farmers must pursue productivity and sustainability. We connect the best products, technologies, and services, to positively transform agriculture, impact food systems and, ultimately, society. By pooling our expertise and resources, we can make a meaningful change," said Marko Grozdanovic, Senior Vice President Global Marketing at BASF Agricultural Solutions.
In July 2023, UPL Ltd. ('UPL') a global provider of sustainable agricultural solutions, has announced a new agreement with the University of Arkansas System Division of Agriculture (UADA) for exclusive access to UADA's filed patents covering the novel use of Fenclorim as a seed treatment with micro-encapsulated herbicides to protect crops against weeds.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.